10x Genomics (TXG) EPS (Weighted Average and Diluted) (2019 - 2026)
10x Genomics' (TXG) quarterly EPS (Weighted Average and Diluted) came in at -$0.1 in Q1 2026, up 64.29% year-on-year from -$0.06 in Q1 2025, and up 23.08% quarter-over-quarter from -$0.13 in Q4 2025.
10x Genomics (TXG) EPS (Weighted Average and Diluted) (2019 - 2026) Analysis & Trends
10x Genomics has disclosed EPS (Weighted Average and Diluted) across 8 years of filings, most recently posting -$0.1 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.1, up 64.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.17 (up 87.02% YoY), and the FY2025 annual result was -$0.35, up 76.97% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.1 for Q1 2026 at 10x Genomics, up from -$0.13 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.28 in Q2 2025 to a low of -$0.79 in Q3 2023.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.37 (2022), against an average of -$0.33.
- Across the five-year window, EPS (Weighted Average and Diluted) slumped 470.0% in 2022 and jumped 187.5% in 2025, its largest moves.
- 10x Genomics' EPS (Weighted Average and Diluted) stood at -$0.15 in 2022, then plunged by 173.33% to -$0.41 in 2023, then rose by 0.0% to -$0.41 in 2024, then surged by 68.29% to -$0.13 in 2025, then gained by 23.08% to -$0.1 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.1 (Q1 2026), -$0.13 (Q4 2025), and -$0.22 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.57 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 0.41 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -0.10 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.10 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.22 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.25 |
| 10 | Teladoc Health | 1.45 Bn | 696.57 Mn | 562.57 Mn | -0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.13 |
| Sep 30, 2025 | -0.22 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | -0.28 |
| Dec 31, 2024 | -0.41 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.32 |
| Mar 31, 2024 | -0.50 |
| Dec 31, 2023 | -0.41 |
| Sep 30, 2023 | -0.79 |
| Jun 30, 2023 | -0.53 |
| Mar 31, 2023 | -0.44 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -0.38 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -0.10 |